http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
-
Surge Battery Metals Provides Corporate Update and Announces Financing
-
AbbVie to Host First-Quarter 2025 Earnings Conference Call
-
FluidForm Bio™ Announces Participation in Venture Summit West
-
Blue Cross Blue Shield of Massachusetts to Provide Free Bluebikes Credit for Riders Affected by 2025 MBTA Closures
-
Y-12 Federal Credit Union Upgrades Fleet, Enhances Self-Service Banking with NCR Atleos
-
Afinida Reports Increase of Nearly $3.3 Million in Net Revenues for 2024
-
Dow and X-energy Submit Construction Permit Application to the U.S. Nuclear Regulatory Commission for Proposed Advanced Nuclear Project in Texas
-
Survey of High School Juniors and Seniors Reveals High Levels of Unpreparedness to Manage Personal Finances, Eagerness to Learn
-
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics
-
Palatin Technologies (PTN) Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
-
DocGo Earns Great Place To Work Certification™ For the Third Time in a Row
-
SAB BIO Reports Full Year 2024 Operating and Financial Results
-
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference
-
DeFi Technologies Inc. Announces Record 2024 Financial Results: Adjusted Revenues of C$204.4 million (US$144.8 million), Adjusted EBITDA of $116.1 million (US$80.4 million) and Adjusted Net Income of
-
Realbotix to Showcase Humanoid Robot at DiscoveryX Conference in Toronto, April 16–17
-
Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
-
Calamos Announces Cap Ranges of Principal Protected Bitcoin ETFs April Series on the Heels of a Successful Inaugural Launch
-
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
-
Moderna (MRNA) Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
-
Ionis to present at upcoming investor conferences
-
HilltopAds' New DirectLink Feature: Maximize Your Traffic Monetization from Social Media
-
Blaies Named Women In Trucking Association's 2025 Driver of the Year
-
Industrial Scientific Continues to Streamline Gas Detection Safety with New Area Monitor
-
Biptap is Building the Worlds First Omnibank
-
CD&R Appoints Walt Bettinger, Former CEO of Charles Schwab, as Senior Advisor - Financial and Technology Services
-
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
-
West Point Gold Expands Current Drill Program to 5,000m
-
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
-
BD Named One of America's Most Innovative Companies by Fortune
-
Global Dash Cam Market Leader Nextbase Makes AI Acquisition for Next Generation of Innovation
-
Skypace Enhances Speed and Accuracy of Freight Bookings with Descartes Rate Management Solution
-
Vext Delivers Solid Q4 Financial Results - Turning Point as Ohio Operations Gain Momentum
-
Westport Reports Fourth Quarter and Full Year 2024 Results
-
Fighting for Global Gender Justice: Campbell & Company Announces Women's Link Worldwide as its 2025 Equity Partner Program Finalist
-
AM Best Reaffirms "A" (Excellent) Rating for Amerisure Insurance
-
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
-
JK Tech Appoints Sameer Nagpal as President & CEO to Propel Growth in the Gen AI Era
-
Hut 8 and Eric Trump Launch American Bitcoin to Set a New Standard in Bitcoin Mining
-
Ragnarok Landverse: Genesis Grand Launch Set for March 29, 2025
-
Innovative Digital Marketing Solutions for Birmingham Businesses
-
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
-
Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis
-
ROSEN, A TOP-RANKED FIRM, Encourages Venture Global, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VG
-
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Ultra Clean Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UCTT
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO
-
ROSEN, A LEADING LAW FIRM, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZYXI
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TFI International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TFII
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA
-
ROSEN, A LEADING LAW FIRM, Encourages Pony AI Inc. Investors to Inquire About Securities Class Action - PONY
